FRIDAY, July 9, 2021 (HealthDay News) — Why do some people infected with SARS-CoV-2 have either no or negligible symptoms, while others sicken and die? Scientists who’ve pinpointed several genetic markers associated with severe COVID-19 say their findings could provide answers to that important question — and targets for futureContinue Reading
THURSDAY, July 1, 2021 (HealthDay News) — A gene therapy aimed at freeing the heart’s capacity for self-repair has shown early promise in an animal study. The study — done in pigs — found that the treatment approach was not only feasible, but also improved the animals’ heart function afterContinue Reading
WEDNESDAY, June 30, 2021 (HealthDay News) — A gene variant may be driving high rates of unnecessary bone marrow biopsies in Black Americans, researchers say. The variant is responsible for lower white blood cell levels in some healthy Black people, the investigators said. “We’ve essentially created this racial health disparityContinue Reading
TUESDAY, June 29, 2021 (HealthDay News) — Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure. “There are many different types of amyloidosis,” explained study author Dr. Julian Gillmore, aContinue Reading
MONDAY, June 21, 2021 (HealthDay News) — Researchers say they’ve identified a new gene associated with an increased risk of amyotrophic lateral sclerosis (ALS) — and that their discovery could lead to improved treatments for the deadly disease. ALS — also called Lou Gehrig’s disease — is a rare, progressiveContinue Reading
MONDAY, June 7, 2021 (HealthDay News) — Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds. “We were certainly disappointed in the results,” said study co-author Dr. Imre Noth, chief of pulmonary andContinue Reading
FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading
FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage inContinue Reading
THURSDAY, June 3, 2021 (HealthDay News) — Could getting out of bed just one hour earlier every day lower your risk for depression? Yes, claims new research that found an earlier start to the day was tied to a 23% lower risk of developing the mood disorder. The study ofContinue Reading
WEDNESDAY, June 2, 2021 (HealthDay News) — A new form of amyotrophic lateral sclerosis (ALS) that affects children has been discovered by an international team of researchers. They used advanced genetic techniques to identify 11 such cases in children who had mysterious neurological disorders. Most cases of ALS — alsoContinue Reading